ARYZTA Selling Baked Goods Containing LeenLife Omega-3 Product

VANCOUVER, BC / ACCESSWIRE / April 19, 2016 / LeenLife Pharma International Inc. (CSE: LLP) (“LeenLife” or the “Company”) is pleased to announce that after several months of testing, technological studies and satisfactory consumer acceptance, ARYZTA is now selling baked loaves of bread and rolls using LeenLife’s proprietary omega-3 product in Poland. ARYZTA AG is one of the largest producers of frozen bakery products in the world. See link to omega bread: http://www.aryzta.pl/en/products-assortment-breads,s-2. The main features of LeenLife omega-3 products are:

– Can be added to bread and rolls with no separation of ingredients and no reduction in essential omega fatty acids,
– Can be baked or frozen keeping a fresh flavor but with resistance to oxidation,
– No fishy or oily taste,
– Vegan product.

LeenLife has developed a patented process to isolate omega-3 fatty acids from flax seeds. LeenLife products have been developed and researched for over 17 years. For additional information see our website at: http://leenlifepharma.com. Bread offered by ARYZTA according to store posters state that, three slices of omega bread provide the same amount of omega-3 (equivalent) as contained in 1 kg of cod fish. The loaves of bread and rolls containing LeenLife’s omega 3 product are currently being introduced to over 2,700 commercial stores in Poland.

LeenLife plans to bring its proprietary omega fatty acid products to Canada and the United States. LeenLife has developed technology to combine omega fatty acids into various food products such as bread, cheese, noodles, milk, juices and chocolate.

Stan Lis, CEO and a director of the Company, states: “We are very excited to be a part of the growing consumer movement to provide healthy food products. Health awareness is an expanding model driving foods to new levels. Our proprietary omega products are healthy, digestible, vegan and can be an essential part of new food products.”

About LeenLife

For more information, please contact:
Stan Lis, CEO
Tel: 604 764-0518
E-mail: slis@leenlifepharma.com

SOURCE: LeenLife Pharma International Inc.

ReleaseID: 438999